Myocardial reperfusion injury [13]

New England Journal of Medicine

Volumn 357, Issue 23, 2007, Pages 2408-

  Forman, Mervyn B ^a   Jackson, Edwin K ^b  

^a North Atlanta Cardiovascular Associates PC   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE;

CELL DEATH; CONGESTIVE HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART VENTRICLE FUNCTION; HUMAN; LETTER; MORTALITY; MUSCLE CELL; PRIORITY JOURNAL; REPERFUSION INJURY; TISSUE PERFUSION;

EID: 36849003518     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc072913     Document Type: Letter

References (4)

1. Forman MB, Stone GW, Jackson EK. Role of adenosine in acute myocardial infarction. Cardiovasc Drug Rev 2006;24:116-47.
2. Forman MB, Jackson EK. Importance of tissue perfusion in STEMI patients undergoing reperfusion strategies: role of adenosine. Clin Cardiol 2007;30:583-5.
3. Ross AM, Gibbons RJ, Stone GW, Kloner RA, Alexander RW. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II). J Am Coll Cardiol 2005;45:1775-80.
4. Kloner RA, Forman MB, Gibbons RJ, Ross AM, Alexander RW, Stone GW. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial. Eur Heart J 2006;27:2400-5.